Data / Research funding / Harm Reduction for Substance Misuse
Harm Reduction for Substance Misuse: 243 NIH awards ($579.1M) to 116 organizations
243 NIH awards ($579.1M) in the NIH spending category Harm Reduction for Substance Misuse, to 116 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
243 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIDA Clinical Trials Network: New York Node (CTN-0139, CTN-0155, CTN-Biostats) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $66,452,521 | March 1, 2025 | February 29, 2032 | MCNEELY, JENNIFER | reporter.nih.gov |
| CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State | NIH | National Institute on Drug Abuse | 2021 to 2023 | $32,731,263 | September 15, 2023 | March 31, 2024 | EL-BASSEL, NABILA | reporter.nih.gov |
| MassHEAL - Reducing overdose deaths by 40% (2019-2023) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $29,970,213 | September 15, 2023 | March 31, 2024 | SAMET, JEFFREY H. | reporter.nih.gov |
| The Florida Node Alliance of the National Drug Abuse Clinical Trials Network (CTN-121) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $26,301,696 | March 1, 2025 | February 29, 2028 | SZAPOCZNIK, JOSE | reporter.nih.gov |
| Optimizing HEALing in Ohio Communities (OHiO)-Health Equity Supplement | NIH | National Institute on Drug Abuse | 2021 to 2023 | $25,859,414 | September 15, 2023 | March 31, 2024 | FREISTHLER, BRIDGET J | reporter.nih.gov |
| NorthStar Node of the NIDA Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $22,374,119 | September 1, 2015 | February 29, 2032 | BART, GAVIN | reporter.nih.gov |
| HEALing Communities Study Health Equity Research | NIH | National Institute on Drug Abuse | 2021 to 2023 | $15,117,207 | April 1, 2019 | September 29, 2024 | OGA, EMMANUEL AJA | reporter.nih.gov |
| Reducing Opioid Mortality in Illinois (ROMI) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $7,594,077 | July 15, 2019 | April 30, 2025 | POLLACK, HAROLD ALEXANDER | reporter.nih.gov |
| Western States Node of the National Drug Abuse Treatment Clinical Trials Network (CTN-139) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,354,769 | March 1, 2025 | March 1, 2032 | KORTHUIS, PHILIP TODD | reporter.nih.gov |
| HEAL Data2Action Modeling and Economic Resource Center | NIH | National Institute on Drug Abuse | 2022 to 2025 | $6,550,146 | September 30, 2022 | August 31, 2027 | SCHACKMAN, BRUCE R | reporter.nih.gov |
| A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | NIH | National Institute on Drug Abuse | 2023 to 2024 | $6,087,655 | September 1, 2023 | August 31, 2025 | LI, XINHUA | reporter.nih.gov |
| Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $5,664,540 | March 1, 2025 | February 29, 2032 | HATCH, MARY AKIKO | reporter.nih.gov |
| HEAL Research on Interventions for Stability and Engagement (RISE) Network Coordination Center | NIH | National Institute on Drug Abuse | 2024 to 2025 | $5,088,719 | September 30, 2022 | June 30, 2027 | CANCE, JESSICA DUNCAN | reporter.nih.gov |
| Rapid Actionable Data for Opioid Response in Kentucky (RADOR-KY) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $4,881,729 | September 30, 2022 | August 31, 2027 | SLAVOVA, SVETLA STEFANOVA | reporter.nih.gov |
| Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy - Yale Resource Center (MIRHIQL-YRC) | NIH | National Institute on Drug Abuse | 2023 | $4,626,338 | August 15, 2023 | July 31, 2026 | BECKER, WILLIAM C | reporter.nih.gov |
| National Drug Early Warning System Coordinating Center (NDEWS) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,490,739 | April 1, 2020 | February 28, 2030 | COTTLER, LINDA B. | reporter.nih.gov |
| Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade. | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,391,293 | September 1, 2021 | June 30, 2027 | SHERMAN, SUSAN G. | reporter.nih.gov |
| A comparative evaluation of overdose prevention programs in New York City and Rhode Island | NIH | National Institute on Drug Abuse | 2023 to 2025 | $4,373,618 | May 1, 2023 | February 28, 2027 | CERDA, MAGDALENA | reporter.nih.gov |
| Promoting HIV risk reduction among people who inject drugs: A stepped care approach using contingency management with PrEP navigation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,159,587 | July 1, 2020 | May 31, 2027 | EDELMAN, E. JENNIFER | reporter.nih.gov |
| Novel Therapeutics for Opioid Use Disorder in the Acute Overdose and Maintenance Settings | NIH | National Institute on Drug Abuse | 2022 to 2023 | $4,143,992 | September 30, 2019 | August 31, 2025 | GEHLERT, DONALD R | reporter.nih.gov |
| Using SMART Design to Identify an Effective and Cost-Beneficial Approach to Preventing OUD in Justice-Involved Youth | NIH | National Institute on Drug Abuse | 2021 to 2023 | $4,080,444 | September 30, 2019 | August 31, 2024 | AHRENS, KYM R | reporter.nih.gov |
| Making Better Decisions: Policy Modeling for AIDS and Drug Abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,865,844 | September 25, 2022 | January 31, 2029 | OWENS, DOUGLAS K | reporter.nih.gov |
| An automated portable system for detecting and treating opioid induced respiratory depression | NIH | National Institute on Drug Abuse | 2022 to 2024 | $3,830,637 | April 1, 2022 | February 28, 2026 | MACKIE, KENNETH | reporter.nih.gov |
| Nalmefene Implant for the Long-Term Treatment of Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2025 | $3,450,000 | September 15, 2018 | January 31, 2028 | PATEL, RAJESH A | reporter.nih.gov |
| UnityPhilly Response App for Overdose Reversal: Assessing Citywide Effectiveness and Sustainability | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,424,229 | September 30, 2023 | July 31, 2028 | LANKENAU, STEPHEN E | reporter.nih.gov |
| SAIA-PrEP: a systems analysis and improvement approach to optimize PrEP implementation in syringe service programs | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,418,213 | September 1, 2022 | June 30, 2027 | BAZZI, ANGELA ROBERTSON | reporter.nih.gov |
| Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials | NIH | National Institute on Drug Abuse | 2025 | $3,410,308 | September 30, 2022 | July 31, 2028 | PRAVETONI, MARCO | reporter.nih.gov |
| Evaluating the impact of fentanyl test strip use among rural and urban populations | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,392,442 | July 1, 2021 | April 30, 2027 | MICHAELS, NICHOLE L | reporter.nih.gov |
| Evaluation of a community-based education, navigation, and support (CENS) intervention to reduce opioid-related harms among military veterans | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,379,762 | September 30, 2021 | July 31, 2027 | BENNETT, ALEXANDER S | reporter.nih.gov |
| Promoting remote and secondary risk prevention services in rural settings | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,349,340 | September 30, 2022 | July 31, 2027 | PHO, MAI TUYET | reporter.nih.gov |
| Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS) | NIH | National Institute on Drug Abuse | 2024 | $3,330,528 | September 30, 2022 | August 31, 2027 | AALSMA, MATTHEW | reporter.nih.gov |
| Evaluating naloxone-on-release from incarceration as community overdose prevention | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,318,365 | June 15, 2022 | April 30, 2027 | DAVIDSON, PETER JOHN | reporter.nih.gov |
| A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,292,995 | July 1, 2020 | May 31, 2027 | LATKIN, CARL A | reporter.nih.gov |
| Reducing Alcohol Involved Sexual violence in higher Education (RAISE) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,275,604 | August 20, 2014 | May 31, 2027 | KAZMERSKI, TRACI M | reporter.nih.gov |
| Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,234,132 | August 1, 2023 | May 31, 2028 | FALADE-NWULIA, OLUWASEUN | reporter.nih.gov |
| Expansion of Mail-Delivered Harm Reduction Services in the U.S. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,156,884 | September 30, 2022 | September 29, 2026 | BEHRENDS, CZARINA NAVOS | reporter.nih.gov |
| Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for PLWH who use drugs | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,152,106 | September 30, 2021 | June 30, 2027 | HAWK, MARY ELIZABETH | reporter.nih.gov |
| Implementation of Overdose Prevention Practices in Permanent Supportive Housing | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,104,337 | May 1, 2022 | March 31, 2027 | DORAN, KELLY | reporter.nih.gov |
| The short and long-term dynamics of opioid/stimulant use: Mixed methods to inform overdose prevention and treatment related to polysubstance use | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,051,259 | September 30, 2022 | July 31, 2027 | GENBERG, BECKY LYNN | reporter.nih.gov |
| Implementing and evaluating the impact of novel mobile harm reduction services on overdose among women who use drugs: The SHOUT study. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,024,580 | September 30, 2022 | July 31, 2027 | SHERMAN, SUSAN G. | reporter.nih.gov |
| Counteracting Structural Barriers to Increase Access to Medications for Opioid Use Disorder (MOUD) Among Unhoused Montanans | NIH | Office of the Director, National Institutes of Health | 2023 to 2025 | $2,999,246 | September 22, 2023 | September 21, 2028 | RAMOS, REBECCA | reporter.nih.gov |
| NX90: A Treatment for Overdose Caused by High Potency Opioids | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,946,808 | September 30, 2024 | August 31, 2026 | VORONKOV, MICHAEL V. | reporter.nih.gov |
| Assessing the Reach, Effectiveness, and Implementation of Multiple Interventions | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,900,711 | September 30, 2022 | July 31, 2027 | KRAL, ALEXANDER H | reporter.nih.gov |
| Efficacy of a community-based PrEP uptake intervention for people who inject drugs in the US Northeast | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,883,810 | July 1, 2020 | May 31, 2026 | BIELLO, KATIE BROOKS | reporter.nih.gov |
| Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,842,189 | November 1, 2021 | October 31, 2026 | DAHARI, HAREL | reporter.nih.gov |
| Studying How State and Local Health Services Delivery Policies can Mitigate the Effects of Disasters on Drug Addiction Treatment and Overdose: A Mixed-Methods Study of COVID-19. | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,829,066 | August 1, 2021 | May 31, 2026 | EISENBERG, MATTHEW | reporter.nih.gov |
| Mobile health strategies to support longitudinal engagement in comprehensive, community-based prevention services for people who use drugs | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,786,936 | September 30, 2022 | July 31, 2027 | WESTERGAARD, RYAN PATRICK | reporter.nih.gov |
| Evaluation of a Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Risky Alcohol Use among Individuals Vulnerable to HIV/AIDS | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,772,306 | August 15, 2022 | May 31, 2027 | LAUCKNER, CAROLYN | reporter.nih.gov |
| Opioid Policy Model | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,750,956 | April 1, 2020 | January 31, 2026 | BOBASHEV, GEORGIY | reporter.nih.gov |
| Peer Engagement in Methamphetamine Harm-Reduction with Contingency Management (PEER-CM) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,732,822 | September 30, 2022 | July 31, 2027 | KORTHUIS, PHILIP TODD | reporter.nih.gov |
| Development of negative allosteric modulators at the mu opioid receptor | NIH | National Institute on Drug Abuse | 2025 | $2,664,000 | September 1, 2025 | August 31, 2027 | MAJUMDAR, SUSRUTA | reporter.nih.gov |
| Stage II Efficacy Trial of an Adapted Brief Intervention to enhance healthcare and health outcomes among Hispanics | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,644,898 | August 10, 2022 | June 30, 2027 | FIELD, CRAIG A | reporter.nih.gov |
| A network-based, mixed methods study to identify and support multiple overdose responders and inform overdose prevention interventions | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,631,207 | September 30, 2022 | July 31, 2027 | WAGNER, KARLA D. | reporter.nih.gov |
| Genetic Variation in Opioid Induced Respiratory Depression in Mice | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,624,578 | April 1, 2020 | January 31, 2026 | BUBIER, JASON A | reporter.nih.gov |
| Recruitment for the efficacy trial of Tele-Harm Reduction in a federally qualified health center operated syringe services program | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,609,496 | May 1, 2021 | April 30, 2026 | TOOKES, HANSEL EMORY | reporter.nih.gov |
| Risk Factors for AIDS among persons who inject drugs: HIV transmission during and after the pandemic | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,592,727 | September 10, 1994 | May 31, 2027 | MCKNIGHT, COURTNEY | reporter.nih.gov |
| Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,586,219 | September 30, 2022 | June 30, 2027 | CERDA, MAGDALENA | reporter.nih.gov |
| Improving Access to Naloxone to Prevent Opioid Overdose Deaths Within Community-based Programs that Serve People Who Use Drugs | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,575,705 | September 15, 2022 | June 30, 2027 | LAMBDIN, BARROT HOPKINS | reporter.nih.gov |
| A Naloxone Parachute: Novel Wearable Dual-Sensor Regional Oximeter to Detect Opioid-Induced Hypoxia and Enable Emergent Naloxone Rescue | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,550,000 | May 1, 2022 | October 31, 2025 | HITE, DESISLAVA ZLATANOVA | reporter.nih.gov |
| IND-enabling development of a long-duration antagonist to treat opioid overdose | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,545,988 | September 15, 2023 | February 28, 2027 | ZANA, LAWRENCE J | reporter.nih.gov |
| 4th Generation e-cigarettes in African American Smokers: Reducing Harm and Quitting Combustible Cigarettes in Dual Users | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,524,937 | May 14, 2022 | February 28, 2027 | NOLLEN, NICOLE L | reporter.nih.gov |
| Taking Our Shot: Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV | NIH | National Institute on Drug Abuse | 2024 | $2,460,000 | July 1, 2024 | June 30, 2028 | APPA, AYESHA A | reporter.nih.gov |
| Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,437,500 | May 1, 2019 | April 30, 2025 | ALBARRACIN, DOLORES | reporter.nih.gov |
| Effectiveness and impact of counseling enhanced with electronic cigarettes for harm reduction in smokers with opioid use disorder | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,424,067 | August 15, 2022 | April 30, 2027 | EL-SHAHAWY, OMAR | reporter.nih.gov |
| Creating a novel place-based measure to explain geographic variability in naloxone access to reduce opioid overdose deaths | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,391,879 | September 26, 2022 | June 30, 2027 | CARPENTER, DELESHA MILLER | reporter.nih.gov |
| Assessing the Impact of Emergency Medical Services System Changes to Overdose Response: The ORCID Study | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,386,732 | September 1, 2023 | July 31, 2028 | VAN DRAANEN, JENNA | reporter.nih.gov |
| Kentucky Outreach Service Kiosk (KyOSK): Reducing Overdose, Hepatitis C, and Other Drug-related Risks in Rural Appalachia through Health Kiosks | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,359,307 | August 15, 2022 | June 30, 2027 | YOUNG, APRIL MARIE | reporter.nih.gov |
| Predicting fatal and non-fatal overdose in Los Angeles County with Rapid Overdose Surveillance Dashboard to target street-based addiction treatment and harm reduction services | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,355,267 | September 30, 2022 | August 31, 2027 | SHOVER, CHELSEA LEIGH | reporter.nih.gov |
| Examining the Impact of the Twin Epidemics of Methamphetamine and Opioid Use on Overdose, Risky Sex and Treatment Engagement among PWUD in Two Rural Appalachian Cohorts | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,345,140 | September 1, 2012 | March 31, 2028 | HAVENS, JENNIFER R | reporter.nih.gov |
| The Impact of Community Infrastructure Reinvestment Programs on Opioid Misuse and Opioid Overdose | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,257,300 | September 30, 2023 | August 31, 2028 | NESOFF, ELIZABETH | reporter.nih.gov |
| The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,243,163 | August 15, 2019 | May 31, 2025 | MARSHALL, BRANDON DAVID LEWIS | reporter.nih.gov |
| Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,236,493 | September 30, 2019 | July 31, 2025 | MARSHALL, BRANDON DAVID LEWIS | reporter.nih.gov |
| Reversing Overdose Epidemics through Simulation, Collaboration, and Unified Efforts (RESCUE) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,189,222 | September 15, 2024 | July 31, 2028 | ZANG, XIAO | reporter.nih.gov |
| Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,166,179 | July 1, 2022 | May 31, 2026 | HEFFRON, RENEE A. | reporter.nih.gov |
| Non-Cigarette Tobacco Products as Harm Reduction Tools in Smokers Who Failed to Quit With Traditional Methods | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,120,389 | September 1, 2023 | July 31, 2028 | SMITH, TRACY TAYLOR | reporter.nih.gov |
| Responding to the Increase in Substance Use, HIV, HCV, and Overdose in New England (RISE-NE) | NIH | National Institute on Drug Abuse | 2025 | $2,076,525 | August 15, 2025 | May 31, 2030 | BAZZI, ANGELA ROBERTSON | reporter.nih.gov |
| Risk Environments for Pregnant/Postpartum Women who Use Drugs: a longitudinal qualitative study | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,061,529 | July 1, 2023 | April 30, 2027 | COOPER, HANNAH LF | reporter.nih.gov |
| Parent-adolescent alcohol discussions and parent alcohol socialization | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $2,061,233 | August 1, 2023 | July 31, 2028 | COLDER, CRAIG R | reporter.nih.gov |
| Efficacy and implementation considerations for a peer-led motivational interviewing intervention to promote uptake of drug checking services and safer drug use behaviors to reduce overdose | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,053,801 | September 15, 2024 | May 31, 2029 | STRATHDEE, STEFFANIE A. | reporter.nih.gov |
| An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the evolving overdose epidemic | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,053,558 | July 1, 2017 | May 31, 2028 | KERR, THOMAS | reporter.nih.gov |
| Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,030,405 | April 20, 2022 | March 31, 2027 | HUTCHISON, KENT E. | reporter.nih.gov |
| DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,025,832 | May 15, 2019 | February 28, 2025 | SCHACKMAN, BRUCE R | reporter.nih.gov |
| Estimating the cost of peer specialists providing comprehensive healthcare services at a syringe services program | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,007,015 | June 1, 2023 | March 31, 2028 | TOOKES, HANSEL EMORY | reporter.nih.gov |
| Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,984,874 | June 1, 2021 | April 30, 2024 | ARONSON, IAN DAVID | reporter.nih.gov |
| Counseling for Harm Reduction and Retention in Medication-assisted treatment - Cherokee Nation (CHaRRM-CN) | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,951,429 | August 1, 2019 | July 31, 2026 | NELSON, LONNIE A. | reporter.nih.gov |
| Rapid, Instrument-free and High Sensitivity Over-the-counter Urine Fentanyl Testing | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,948,098 | April 1, 2024 | March 31, 2027 | XIA, XIAOFENG | reporter.nih.gov |
| Leveraging Data to Action: Accelerating Emergency Department OUD Care by Improving Data Access and Infrastructure | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,947,922 | September 1, 2023 | August 31, 2028 | VENKATESH, ARJUN KRISHNA | reporter.nih.gov |
| Examining the Impact of Stress on the Emotionally Reinforcing Properties of Alcohol in Heavy Social Drinkers: A Multimodal Investigation Integrating Laboratory and Ambulatory Methods | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,878,542 | August 15, 2023 | May 31, 2028 | FAIRBAIRN, CATHARINE | reporter.nih.gov |
| A structural HIV prevention intervention targeting high-risk women | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,872,697 | September 15, 2021 | August 31, 2024 | SHERMAN, SUSAN G. | reporter.nih.gov |
| Development and validation of a novel point-of-care technology for rapid non-targeted identification of emerging opioid and other drug threats | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,866,922 | September 30, 2023 | August 31, 2027 | WERB, DANIEL M | reporter.nih.gov |
| A clinical trial of adaptive treatment for early smoking cessation relapse | NIH | National Cancer Institute | 2023 to 2025 | $1,800,850 | July 1, 2023 | June 30, 2028 | SMITH, TRACY TAYLOR | reporter.nih.gov |
| Multilevel SUD and Overdose Prevention for Rural Youth Involved in County Legal Systems | NIH | National Institute on Drug Abuse | 2024 | $1,751,868 | September 30, 2024 | August 31, 2026 | AHRENS, KYM R | reporter.nih.gov |
| Using data to drive action to reduce opioid overdoses in Seattle, WA | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,723,230 | September 30, 2022 | May 31, 2028 | BANTA-GREEN, CALEB | reporter.nih.gov |
| Developing and testing the Opioid Rapid Response System | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,707,365 | September 30, 2020 | June 30, 2026 | HECHT, MICHAEL | reporter.nih.gov |
| Coalition for harm reduction and prevention (CHRP): Developing and testing a novel Hub and Spoke Model to implement prevention and harm reduction in rural clinics | NIH | National Institute on Drug Abuse | 2024 | $1,594,805 | September 30, 2024 | September 29, 2026 | LIN, LEWEI ALLISON | reporter.nih.gov |
| A Rapid, Sensitive and Instrument-free Oral Fluid Fentanyl Test | NIH | National Institute on Drug Abuse | 2025 | $1,576,513 | June 15, 2025 | May 31, 2027 | XIA, XIAOFENG | reporter.nih.gov |
| RTI HEAL Harm Reduction Network Coordination Center | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,556,321 | September 30, 2022 | June 30, 2027 | OGA, EMMANUEL AJA | reporter.nih.gov |
| Sentanyl II: A Multi-State Analysis of Fentanyl/Analogs, Naloxone, and Clinical Features of Non-Fatal Opioid Overdose | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,549,064 | July 15, 2022 | June 30, 2024 | MERCHANT, ROLAND C | reporter.nih.gov |
| Engaging People Who Use Drugs in Harm Reduction Service Delivery: An Intravention to Reduce Risk of HIV, HCV, Overdose, and Injection-related Infections in Rural Appalachia | NIH | National Institute on Drug Abuse | 2024 | $1,533,697 | September 30, 2024 | August 31, 2026 | YOUNG, APRIL MARIE | reporter.nih.gov |
| A social diffusion fatal overdose prevention intervention: Assessing the effectiveness of people who use opioids as peer educators in training using & non-using networks on overdose & stigma reduction | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,527,671 | June 1, 2023 | April 30, 2029 | LATKIN, CARL A | reporter.nih.gov |
| Neurobehavioral mechanisms underlying xylazine and fentanyl co-use and withdrawal | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,511,220 | June 15, 2023 | April 30, 2028 | GIPSON-REICHARDT, CASSANDRA D | reporter.nih.gov |
| Novel antagonists as fentanyl overdose rescue therapies | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,464,573 | August 1, 2022 | July 31, 2024 | TRAYNOR, JOHN R. | reporter.nih.gov |
| Optimizing a Just-in-Time Adaptive Intervention to Increase Uptake of Chemsex Harm Reduction Services in MSM: A Micro-randomized Trial | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,457,846 | July 15, 2024 | April 30, 2029 | SHRESTHA, ROMAN | reporter.nih.gov |
| Adapting a Network-Oriented HIV Prevention Intervention for Rural People Who Inject Drugs (PWID) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,448,353 | May 1, 2024 | February 28, 2029 | ALLEN, SEAN T | reporter.nih.gov |
| Kentucky Women's Justice Community Overdose Innovation Network - Phase II | NIH | National Institute on Drug Abuse | 2025 | $1,445,488 | September 1, 2025 | May 31, 2030 | STATON, MICHELE | reporter.nih.gov |
| TechMPower: Advancing HIV/SUD Care and Service Delivery for People Involved in the Criminal Legal System | NIH | National Institute on Drug Abuse | 2025 | $1,431,206 | May 15, 2024 | July 31, 2029 | HUNT, TIMOTHY | reporter.nih.gov |
| Harm Reduction for Smokers with Mental Illness: RCT of E-cigarette Provision with or without Behavioral Support to Boost Switching | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,413,427 | June 1, 2024 | March 31, 2028 | PRATT, SARAH ILANA | reporter.nih.gov |
| Substance use in PRegnancy and the mOrbidity Mortality rISk Environment (PROMISE) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,408,496 | July 1, 2024 | April 30, 2029 | COOPER, HANNAH LF | reporter.nih.gov |
| Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,393,884 | September 15, 2022 | March 31, 2026 | TORRALVA, PHILLIP RANDOLPH | reporter.nih.gov |
| Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,343,426 | July 1, 2024 | April 30, 2029 | BARTHOLOMEW, TYLER SCOTT | reporter.nih.gov |
| Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer Disparities in Appalachia | NIH | National Cancer Institute | 2024 to 2025 | $1,311,113 | September 4, 2024 | August 31, 2029 | KELLER-HAMILTON, BRITTNEY L | reporter.nih.gov |
| Dual use of combustible and electronic cigarettes: A fine-grained naturalistic cohort study to investigate dynamic use patterns and trajectories that lead to smoking cessation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,306,268 | July 1, 2024 | April 30, 2029 | CARPENTER, MATTHEW J | reporter.nih.gov |
| Evaluating a tobacco harm reduction strategy among clients enrolled in substance use disorder treatment | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,283,188 | September 15, 2024 | May 31, 2029 | MCCLURE, ERIN A | reporter.nih.gov |
| Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers | NIH | National Cancer Institute | 2024 to 2025 | $1,270,404 | April 1, 2024 | March 31, 2028 | AUDRAIN-MCGOVERN, JANET E | reporter.nih.gov |
| A mixed-methods study of polysubstance use to inform opioid overdose prevention | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,250,072 | July 15, 2020 | May 31, 2025 | LORVICK, JENNIFER | reporter.nih.gov |
| User-centric development of closed-loop therapy for opioid overdose | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,249,134 | September 30, 2022 | December 31, 2028 | LE, VY | reporter.nih.gov |
| A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk | NIH | National Institute on Drug Abuse | 2024 | $1,233,787 | September 30, 2024 | August 31, 2026 | BAGLEY, SARAH M | reporter.nih.gov |
| Recovery Management Checkup Scalability and Sustainability (RMC-SS) Hybrid Experiment: Evaluating Comparability of Client and Implementation Outcomes in Community Organizations Post-Arrest | NIH | National Institute on Drug Abuse | 2025 | $1,195,200 | September 15, 2025 | May 31, 2030 | DENNIS, MICHAEL L. | reporter.nih.gov |
| Project SHIELD: Police Education to Support Public Health in Kentucky | NIH | National Institute on Drug Abuse | 2025 | $1,182,981 | May 15, 2024 | April 30, 2029 | CEPEDA, JAVIER | reporter.nih.gov |
| Data-Driven Approaches for Opioid Use Disorder Treatment, Recovery, and Overdose Prevention in Rural Communities via Mobile Health Clinics and Peer Support Services | NIH | National Institute on Drug Abuse | 2025 | $1,150,429 | September 30, 2023 | August 31, 2029 | RENNERT, LIOR | reporter.nih.gov |
| Using System Dynamics Modeling to Foster Real-time Connections to Care | NIH | National Institute on Drug Abuse | 2025 | $1,142,392 | September 30, 2022 | April 30, 2028 | HECKMANN, REBEKAH | reporter.nih.gov |
| Harnessing big data to arrest the HIV/HCV/opioid syndemic in the rural and urban South | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,115,625 | June 1, 2023 | March 31, 2028 | REBEIRO, PETER F | reporter.nih.gov |
| TechMPower: Advancing HIV/SUD Care and Service Delivery for People Involved in the Criminal Legal System | NIH | National Institute on Drug Abuse | 2024 | $1,105,729 | May 15, 2024 | October 31, 2025 | FRYE, VICTORIA | reporter.nih.gov |
| Yakama Nation: Native Collective Research Effort to Enhance Wellness Program | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,093,447 | August 15, 2024 | July 31, 2026 | SALUSKIN, KATHERINE R | reporter.nih.gov |
| Chicago Data-driven OUD Screening, Engagement, Treatment and Planning (C-DOSETaP) System | NIH | National Institute on Drug Abuse | 2023 | $1,093,394 | September 1, 2023 | August 31, 2025 | KARNIK, NIRANJAN SUBHASH | reporter.nih.gov |
| Methadone-Maintained Smokers Switching to E-Cigarettes | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,058,359 | September 30, 2021 | June 30, 2025 | ABRANTES, ANA M | reporter.nih.gov |
| A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,012,500 | April 1, 2023 | February 29, 2028 | ALHAMADSHEH, MAMOUN M | reporter.nih.gov |
| "A friend in my pocket": mHealth intervention to reduce overdose risk among people who engage in polysubstance use | NIH | National Institute on Drug Abuse | 2024 | $974,317 | September 15, 2024 | August 31, 2026 | LORVICK, JENNIFER | reporter.nih.gov |
| Optimizing HIV Prevention Among High-Risk Opioid-Dependent Persons | NIH | National Institute on Drug Abuse | 2021 to 2025 | $953,699 | August 15, 2020 | July 31, 2030 | COPENHAVER, MICHAEL | reporter.nih.gov |
| Testing an occupational stress intervention for harm reduction workers in substance misuse settings | NIH | National Institute on Drug Abuse | 2023 to 2024 | $943,897 | September 30, 2023 | August 31, 2025 | CREECH, SUZANNAH K | reporter.nih.gov |
| Data-Driven Approaches for Opioid Use Disorder Treatment, Recovery, and Overdose Prevention in Rural Communities via Mobile Health Clinics and Peer Support Services | NIH | National Institute on Drug Abuse | 2023 | $942,574 | September 30, 2023 | August 31, 2025 | RENNERT, LIOR | reporter.nih.gov |
| Onsite PTSD Treatment to Improve MOUD Outcomes (OPTIMO): a hybrid Type 1 effectiveness-implementation trial of harm reduction PTSD care at syringe service programs | NIH | National Institute on Drug Abuse | 2023 | $915,814 | September 30, 2023 | August 31, 2025 | LOPEZ-CASTRO, TERESA | reporter.nih.gov |
| Project SHIELD: Police Education to Support Public Health in Kentucky | NIH | National Institute on Drug Abuse | 2024 | $900,881 | May 15, 2024 | April 30, 2025 | CEPEDA, JAVIER | reporter.nih.gov |
| Preventing Overdose in Supportive Housing: Stepped Wedge Randomized Controlled Trial of a Multi-Sector, Upstream Intervention | NIH | National Institute on Drug Abuse | 2025 | $873,465 | July 15, 2025 | June 30, 2027 | DORAN, KELLY | reporter.nih.gov |
| Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose | NIH | National Institute on Drug Abuse | 2025 | $849,872 | September 30, 2021 | November 30, 2028 | CHACKERIAN, BRYCE C | reporter.nih.gov |
| Navigating the Fentanyl Age with Community Drug Checking | NIH | National Institute on Drug Abuse | 2022 to 2023 | $820,722 | September 1, 2022 | July 31, 2024 | GREEN, TRACI C | reporter.nih.gov |
| Together Against Overdose: community developed technology to encourage drug checking, distribution of harm reduction supplies, and linkage to services | NIH | National Institute on Drug Abuse | 2024 | $803,573 | September 30, 2024 | August 31, 2026 | ARONSON, IAN DAVID | reporter.nih.gov |
| Integrated HIV and Overdose Prevention in Pharmacies: Assessing Availability and Implementation Strategies in Different Policy Environments (HIP-Pharm) | NIH | National Institute on Drug Abuse | 2025 | $762,479 | July 1, 2025 | March 31, 2030 | LANCASTER, KATHRYN ELIZABETH | reporter.nih.gov |
| Our Healing Journey: A Cultural and Traditional Response to the Opioid Epidemic | NIH | National Institute on Drug Abuse | 2024 to 2025 | $759,957 | August 15, 2024 | July 31, 2026 | WEBB, KELLIE | reporter.nih.gov |
| PATH to reducing burnout among peers who deliver harm reduction services: Improving workforce and service system outcomes through a combined eLearning and group consultation intervention | NIH | National Institute on Drug Abuse | 2024 | $759,748 | September 30, 2024 | August 31, 2026 | WATSON, DENNIS PAUL | reporter.nih.gov |
| Understanding Factors that Limit Access to Opioid Use Disorder Treatment in the Hospital to Inform Innovative Approaches to Expand Hospital-Based Treatment | NIH | National Institute on Drug Abuse | 2021 to 2024 | $756,172 | April 1, 2020 | March 31, 2026 | CALCATERRA, SUSAN L | reporter.nih.gov |
| An Integrated HIV/OEND Peer Navigation Intervention for Latinx People Who Use and Sell Drugs (PWUSD) | NIH | National Institute on Drug Abuse | 2025 | $753,286 | August 15, 2025 | July 31, 2028 | MONTERO, FERNANDO | reporter.nih.gov |
| Increasing naloxone availability and use in high-risk settings: public libraries as partners for reducing opioid overdose mortality | NIH | National Institute on Drug Abuse | 2025 | $721,217 | May 15, 2025 | February 28, 2030 | CANNUSCIO, CAROLYN CHRISTA | reporter.nih.gov |
| Evaluating Vending Machines providing Naloxone to Prevent Overdose in American Indian Communities | NIH | National Institute on Drug Abuse | 2024 | $716,181 | April 1, 2024 | March 31, 2025 | GAINES, TOMMI LYNN | reporter.nih.gov |
| Feasibility of Leveraging the National PulsePoint CPR Responder Network to Facilitate Overdose Education and Naloxone Distribution | NIH | National Institute on Drug Abuse | 2023 to 2025 | $713,250 | September 15, 2023 | August 31, 2026 | AGLEY, JON | reporter.nih.gov |
| Prevention Ambassadors: an HIV self-testing intervention to promote HIV service engagement in the networks of SSP clients | NIH | National Institute on Drug Abuse | 2023 to 2025 | $709,852 | April 15, 2023 | February 28, 2027 | PINES, HEATHER ALISA | reporter.nih.gov |
| Reducing HIV-related Intersectional Stigma and Risk among People who Inject Drugs in a High Risk International Setting | NIH | National Institute on Drug Abuse | 2023 to 2025 | $709,611 | September 1, 2023 | July 31, 2027 | SMITH, LARAMIE RAE | reporter.nih.gov |
| Evaluating Vending Machines providing Naloxone to Prevent Overdose in American Indian Communities | NIH | National Institute on Drug Abuse | 2025 | $702,245 | April 1, 2024 | March 31, 2027 | GAINES, TOMMI L | reporter.nih.gov |
| Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing among Rural Primary Care Providers in Ohio | NIH | National Institute on Drug Abuse | 2022 to 2024 | $697,560 | August 1, 2022 | June 30, 2026 | FRANZ, BERKELEY | reporter.nih.gov |
| Evaluating Population-Based Strategies for Rural Smoking Cessation | NIH | National Institute on Minority Health and Health Disparities | 2025 | $694,771 | March 1, 2025 | November 30, 2029 | CARROLL, DANA MOWLS | reporter.nih.gov |
| eHaRT-A: Adapting an evidence-based, in-person harm reduction treatment into a virtual care telehealth intervention for people with lived experience of homelessness and alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $691,568 | September 13, 2022 | August 31, 2027 | FROHE, TESSA MARIE | reporter.nih.gov |
| Applying a multiple methods approach to examine spatial and temporal variability in a state's illicit drug market | NIH | National Institute on Drug Abuse | 2025 | $688,271 | June 1, 2025 | February 28, 2030 | HEIMER, ROBERT | reporter.nih.gov |
| Benzodiazepine restrictions and the prevention of overdoses and other harms | NIH | National Institute on Drug Abuse | 2021 to 2024 | $687,794 | July 1, 2021 | December 31, 2025 | WIESE, ANDREW DAVID | reporter.nih.gov |
| Prospective changes in patient-reported and objective functioning following reduction of cannabis use | NIH | National Institute on Drug Abuse | 2025 | $686,692 | September 1, 2025 | July 31, 2030 | TOMKO, RACHEL LYNN | reporter.nih.gov |
| Development and Testing of the Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention for Syringe Service Programs | NIH | National Institute on Drug Abuse | 2025 | $677,250 | June 15, 2025 | May 31, 2028 | NOWOTNY, KATHRYN M | reporter.nih.gov |
| Dissecting the mechanisms underlying fentanyl-induced cardiorespiratory depression | NIH | National Institute on Drug Abuse | 2025 | $671,732 | May 1, 2025 | April 30, 2028 | MORON-CONCEPCION, JOSE A | reporter.nih.gov |
| Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit | NIH | National Cancer Institute | 2025 | $663,554 | August 18, 2025 | July 31, 2030 | AUDRAIN-MCGOVERN, JANET E | reporter.nih.gov |
| Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky | NIH | National Institute on Drug Abuse | 2021 to 2023 | $654,800 | August 1, 2021 | July 31, 2025 | SURRATT, HILARY L | reporter.nih.gov |
| Behavioral Safety and Fentanyl Education: BSAFE | NIH | National Institute on Drug Abuse | 2025 | $629,866 | September 30, 2025 | May 31, 2030 | COFFIN, PHILLIP O | reporter.nih.gov |
| Synthetic Scavenger Medical Countermeasures for Fentanyl | NIH | National Institute on Drug Abuse | 2023 to 2024 | $628,353 | June 1, 2023 | November 30, 2025 | LIU, XIAOHE | reporter.nih.gov |
| Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services | NIH | National Institute on Drug Abuse | 2022 to 2024 | $627,795 | August 15, 2022 | June 30, 2026 | LEWIS, CRYSTAL FULLER | reporter.nih.gov |
| A Novel Harm Reduction Approach for Oncology Outpatients who Smoke and Refuse Traditional Tobacco Treatment | NIH | National Cancer Institute | 2025 | $619,175 | December 1, 2024 | November 30, 2029 | ROJEWSKI, ALANA | reporter.nih.gov |
| Vending machine Naloxone Distribution for Your community (VENDY): Increasing reach and implementation of naloxone distribution | NIH | National Institute on Drug Abuse | 2022 to 2025 | $616,399 | July 15, 2022 | June 30, 2027 | WAGNER, NICOLE MARIE | reporter.nih.gov |
| Navigating the Fentanyl Age with Community Drug Checking | NIH | National Institute on Drug Abuse | 2025 | $609,810 | September 1, 2022 | December 31, 2027 | GREEN, TRACI C | reporter.nih.gov |
| Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment | NIH | National Institute on Drug Abuse | 2021 to 2023 | $603,469 | August 1, 2019 | July 31, 2025 | KAPADIA, SHASHI | reporter.nih.gov |
| Ending HIV and Taming HCV and Overdose Among Puerto Rican PWID in New York City: The Ganchero Intervention | NIH | National Institute on Drug Abuse | 2023 to 2025 | $583,902 | June 1, 2023 | April 30, 2027 | GELPI-ACOSTA, CAMILA | reporter.nih.gov |
| Adapting and Testing a Youth Overdose Prevention Toolkit | NIH | National Institute on Drug Abuse | 2024 | $572,368 | September 30, 2024 | September 29, 2027 | FAST, DANYA | reporter.nih.gov |
| Project HOPE - Exploring the Role of Harm Reduction Vending Machines in Reducing the Risk of HIV Infection and Transmission | NIH | National Institute on Drug Abuse | 2025 | $554,922 | September 1, 2025 | August 31, 2028 | HERRERA, ASHLEIGH NICOLE SCINTA | reporter.nih.gov |
| Mentorship in research on opioid use disorder treatment and HIV prevention | NIH | National Institute on Drug Abuse | 2023 to 2025 | $554,412 | August 15, 2023 | July 31, 2028 | FOX, AARON D | reporter.nih.gov |
| Racial Inequities in Opioid Overdose Prevention: The role of local context in the effectiveness of state-level overdose prevention policies | NIH | National Institute on Drug Abuse | 2023 to 2025 | $550,065 | April 15, 2023 | March 31, 2028 | PAMPLIN, JOHN RICHARD | reporter.nih.gov |
| A user-customizable personalized normative feedback intervention for alcohol harm reduction in young adults: Feasibility, acceptability, and preliminary efficacy. | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $524,812 | September 20, 2024 | August 31, 2027 | LARIMER, MARY E. | reporter.nih.gov |
| Identifying barriers and facilitators of harm reduction among adult dual users of e-cigarettes and cigarettes | NIH | National Institute on Drug Abuse | 2023 to 2025 | $519,012 | June 15, 2023 | May 31, 2028 | OSIBOGUN, OLATOKUNBO | reporter.nih.gov |
| Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform | NIH | National Institute on Drug Abuse | 2024 to 2025 | $506,459 | July 1, 2024 | April 28, 2026 | TOFIGHI, BABAK | reporter.nih.gov |
| Identifying optimal buprenorphine dosing for OUD treatment and prevention of overdose | NIH | National Institute on Drug Abuse | 2025 | $505,573 | July 1, 2022 | November 30, 2027 | BEAUDOIN, FRANCESCA | reporter.nih.gov |
| The Youth Empowerment Study (YES) | NIH | National Institute on Drug Abuse | 2024 | $497,002 | September 30, 2024 | August 31, 2026 | BAGLEY, SARAH M | reporter.nih.gov |
| Optimizing Low Threshold TelePrEP Care in Syringe Service Programs for People who Inject Drugs in Appalachia | NIH | National Institute on Drug Abuse | 2024 to 2025 | $490,910 | May 1, 2024 | April 30, 2027 | SURRATT, HILARY L | reporter.nih.gov |
| Supporting data-driven decision-making to support substance use service expansion policies and to prevent overdoses | NIH | National Institute on Drug Abuse | 2023 | $486,685 | September 1, 2023 | August 31, 2024 | CRUDEN, GRACELYN | reporter.nih.gov |
| A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose | NIH | National Institute on Drug Abuse | 2023 to 2024 | $479,080 | August 1, 2023 | July 31, 2024 | CULLINANE, CONOR R | reporter.nih.gov |
| Xylazine exposure and transitions to low-frequency injecting and injection cessation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $474,583 | August 15, 2024 | July 31, 2026 | MCNEIL, RYAN | reporter.nih.gov |
| Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply | NIH | National Institute on Drug Abuse | 2023 to 2024 | $470,656 | May 1, 2023 | April 30, 2026 | GREEN, TRACI C | reporter.nih.gov |
| Church-Tailored Opioid Overdose Education and Naloxone Distribution to Target Overdose and Stigma Among African-American Communities | NIH | National Institute on Drug Abuse | 2022 to 2023 | $470,578 | April 15, 2022 | February 28, 2027 | JONES, JERMAINE D | reporter.nih.gov |
| Novel Mu Opioid Receptor Modulators to Counteract Synthetic Opioids | NIH | National Institute on Drug Abuse | 2025 | $465,750 | September 1, 2025 | May 31, 2030 | PAGARE, PIYUSHA P | reporter.nih.gov |
| Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs | NIH | National Institute on Drug Abuse | 2024 | $461,653 | June 1, 2021 | April 1, 2025 | ARONSON, IAN DAVID | reporter.nih.gov |
| Developing a Service Planning Tool to Address the Combined HIV and Opioid Epidemics | NIH | National Institute on Drug Abuse | 2025 | $461,491 | August 1, 2025 | July 31, 2027 | ZELENEV, ALEXEI | reporter.nih.gov |
| Comprehensive Telehealth at Syringe Service Programs to Engage People Who Inject Drugs into the HIV Care Continuum | NIH | National Institute on Drug Abuse | 2024 to 2025 | $460,432 | September 15, 2024 | July 31, 2027 | SMITH, M KUMI | reporter.nih.gov |
| Intersectional stigma among rural buprenorphine providers as a barrier to diffusion of harm reduction strategies and interventions to enhance engagement in treatment for HIV and opioid use disorders | NIH | National Institute on Drug Abuse | 2022 to 2023 | $457,883 | July 1, 2022 | June 30, 2024 | MAROTTA, PHILLIP L | reporter.nih.gov |
| Rapid Research for Xylazine Response | NIH | National Institute on Drug Abuse | 2023 to 2024 | $450,313 | September 15, 2023 | August 31, 2025 | GERMAN, DANIELLE | reporter.nih.gov |
| Community-informed approaches to the escalating presence of xylazine in opioids | NIH | National Institute on Drug Abuse | 2023 to 2024 | $447,120 | May 1, 2023 | April 30, 2026 | REED, MEGAN | reporter.nih.gov |
| Assessing fentanyl test strip use accuracy and fentanyl presence in the non-heroin drug supply | NIH | National Institute on Drug Abuse | 2023 to 2024 | $441,826 | May 1, 2023 | April 30, 2026 | REED, MEGAN | reporter.nih.gov |
| Negative allosteric modulation of mu opioid receptors to reverse fentanyl overdose | NIH | National Institute on Drug Abuse | 2024 to 2025 | $435,875 | September 15, 2024 | August 31, 2026 | MACKIE, KENNETH | reporter.nih.gov |
| Informing national overdose prevention and treatment strategies for high-risk adolescents | NIH | National Institute on Drug Abuse | 2024 | $431,750 | September 30, 2024 | September 29, 2026 | BUSHNELL, GRETA | reporter.nih.gov |
| Identifying Stigma Reduction Targets in the Context of an Appalachian HIV Outbreak | NIH | National Institute on Drug Abuse | 2022 to 2023 | $426,105 | August 1, 2022 | July 31, 2025 | POLLINI, ROBIN A | reporter.nih.gov |
| Zebrafish Screens to Identify Agents which Reverse the Effects of Synthetic Opioids | NIH | National Institute on Drug Abuse | 2023 to 2024 | $424,875 | April 1, 2023 | September 30, 2025 | SCHIEFER, ISAAC T | reporter.nih.gov |
| A National Survey on Naloxone Use and Access | NIH | National Institute on Drug Abuse | 2024 | $424,545 | September 15, 2024 | August 31, 2026 | POWELL, DAVID | reporter.nih.gov |
| Dealers, Detectives, and People Who Use Drugs: Triangulating Perspectives to Understand COVID-19’s Impact on the Rural Appalachian Drug Market and Mitigate Downstream Overdose Risk | NIH | National Institute on Drug Abuse | 2022 to 2023 | $419,872 | August 15, 2022 | July 31, 2025 | VICKERS-SMITH, RACHEL | reporter.nih.gov |
| The DOVE Device to Prevent Opioid Overdose Deaths: An Armband That Senses Overdose and Automatically Injects Naloxone | NIH | National Institute on Drug Abuse | 2023 to 2024 | $419,832 | May 1, 2023 | April 30, 2025 | BRENNER, JACOB | reporter.nih.gov |
| Counterfeit Pharmaceuticals: Increased Risks in the Era of Novel Synthetic Opioids and Other Designer Drugs | NIH | National Institute on Drug Abuse | 2022 to 2023 | $415,340 | April 1, 2022 | March 31, 2025 | DANIULAITYTE, RAMINTA | reporter.nih.gov |
| Community Mitigation Against Xylazine | NIH | National Institute on Drug Abuse | 2024 to 2025 | $405,578 | September 1, 2024 | August 31, 2027 | RAY, BRADLEY | reporter.nih.gov |
| Characterizing chemsex patterns and adoption of harm reduction measures among men in the South | NIH | National Institute on Drug Abuse | 2025 | $405,490 | July 15, 2025 | June 30, 2027 | HAIDER, MOHAMMAD RIFAT | reporter.nih.gov |
| Device-Agnostic Hypoxia Detection Software for Overdose Prediction and Positive Reversal Monitoring | NIH | National Institute on Drug Abuse | 2025 | $404,078 | August 15, 2025 | July 31, 2026 | ONI, OLUMUYIWA | reporter.nih.gov |
| Implementation of Contingency Management in a Mobile Low-Threshold Buprenorphine Clinic | NIH | National Institute on Drug Abuse | 2024 to 2025 | $403,920 | April 1, 2024 | March 31, 2028 | MESSMER, SARAH | reporter.nih.gov |
| ODAlert: Wearable Device for Automatic Detection of Opioid-Induced Respiratory Arrest | NIH | National Institute on Drug Abuse | 2024 | $400,000 | September 1, 2024 | August 31, 2025 | VAZIRI, ASHKAN | reporter.nih.gov |
| User-Centric Development of a Detection Module for a Closed-Loop Solution to Opioid Overdose | NIH | National Institute on Drug Abuse | 2025 | $399,715 | August 1, 2025 | July 31, 2027 | LE, VY | reporter.nih.gov |
| Evaluating Smoking Cessation and Harm Reduction Approaches among People Living with HIV/AIDS in South Africa | NIH | Fogarty International Center | 2022 to 2023 | $399,602 | July 1, 2022 | June 30, 2025 | EL-SHAHAWY, OMAR | reporter.nih.gov |
| Growing Xylazine Supply in NC: A Community-Based Investigation of Exposure and Health Consequences | NIH | National Institute on Drug Abuse | 2024 to 2025 | $381,191 | July 15, 2024 | June 30, 2026 | ZIBBELL, JON ERIC | reporter.nih.gov |
| I-Corps for Novel Formulation Technology for Sustained Release Naloxone | NIH | National Institute on Drug Abuse | 2023 to 2024 | $375,000 | March 1, 2024 | September 14, 2024 | TORRES LUNA, CESAR | reporter.nih.gov |
| Development of a mobile harm reduction treatment for alcohol use disorder (mHaRT-A) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 | $369,597 | March 1, 2024 | May 31, 2025 | COLLINS, SUSAN E | reporter.nih.gov |
| Proyecto Vida: Developing an HIV, HCV and opioid use MOST intervention for persons who inject drugs along the Texas-Mexico Border | NIH | National Institute on Drug Abuse | 2024 to 2025 | $366,673 | September 30, 2024 | August 31, 2029 | LUDWIG-BARRON, NATASHA | reporter.nih.gov |
| The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia | NIH | National Institute on Drug Abuse | 2021 to 2023 | $358,694 | March 15, 2019 | August 11, 2023 | LANCASTER, KATHRYN ELIZABETH | reporter.nih.gov |
| A comprehensive device integrating fentanyl test strips with sample preparation features for convenient and discreet fentanyl testing in high-risk environments | NIH | National Institute on Drug Abuse | 2025 | $305,369 | August 1, 2025 | August 31, 2026 | CHUNG, JEANIE | reporter.nih.gov |
| Innovating Technology Solutions for Residents in Supportive Housing Communities with SUD through Community-Engaged Research | NIH | National Institute on Drug Abuse | 2024 | $295,924 | July 1, 2024 | June 30, 2026 | SMITH, DAVID RANDOLPH | reporter.nih.gov |
| Feasibility of Electronic Screening to Identify Risk of Opioid Misuse and Overdose | NIH | National Institute on Drug Abuse | 2024 | $295,876 | September 15, 2024 | August 31, 2025 | FERRARESE, NICK | reporter.nih.gov |
| VisitBoost: A Home Visiting Enhancement to Reduce Harm for Families Affected by Substance Misuse | NIH | National Institute on Drug Abuse | 2023 | $259,611 | September 1, 2023 | May 31, 2025 | SMITH, DAVID RANDOLPH | reporter.nih.gov |
| Research Career Enhancement in Implementation Science to Address Primary Prevention, Harm Reduction, and Evidence-Based Interventions for Opioid Use Disorder from the Emergency Department | NIH | National Institute on Drug Abuse | 2024 to 2025 | $247,860 | June 1, 2024 | May 31, 2028 | KIM, HOWARD S | reporter.nih.gov |
| A Citizen Science Approach to Increase HIV/STI/HCV Testing and Substance Use Service Utilization Among Survivors of Sex Trafficking Living in New York City | NIH | National Institute on Drug Abuse | 2025 | $246,012 | September 1, 2025 | June 30, 2028 | DAVIS, ALISSA | reporter.nih.gov |
| Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists | NIH | National Institute on Drug Abuse | 2023 | $241,500 | April 1, 2022 | March 31, 2025 | HAOUZI, PHILIPPE A | reporter.nih.gov |
| Vending machines: a low-barrier method to deliver harm reduction services in the community | NIH | National Institute on Drug Abuse | 2025 | $200,772 | May 15, 2025 | April 30, 2030 | ZHANG, ALICE | reporter.nih.gov |
| Identifying Low Barrier Wound Care Models for People Who Inject Drugs | NIH | National Institute on Drug Abuse | 2025 | $196,020 | September 1, 2025 | August 31, 2030 | TURI, ELEANOR | reporter.nih.gov |
| Using Implementation Science to Advance Evidence-Based Treatment for Stimulant Use | NIH | National Institute on Drug Abuse | 2025 | $194,098 | January 15, 2025 | December 31, 2029 | ERATH, TYLER GEORGE | reporter.nih.gov |
| Epidemiology of xylazine-associated health harms: a cohort study of people who have injected drugs | NIH | National Institute on Drug Abuse | 2025 | $193,854 | September 1, 2025 | August 31, 2027 | FEDER, KENNETH | reporter.nih.gov |
| Multi-Level Risk of Polysubstance use Trajectory and Leveraging Machine Learning Approaches to Detect Overdose Risk | NIH | National Institute on Drug Abuse | 2025 | $193,644 | September 1, 2025 | August 31, 2030 | CADET, KECHNA | reporter.nih.gov |
| Fentanyl Overdose, Anhedonia and Relapse Risk | NIH | National Institute on Drug Abuse | 2025 | $193,250 | September 15, 2025 | August 31, 2027 | BYRNES, ELIZABETH M | reporter.nih.gov |
| Towards a harm reduction approach to perinatal cannabis use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $191,298 | July 15, 2024 | June 30, 2027 | ALBANESE, ARIANA | reporter.nih.gov |
| Fentanyl and Xylazine Interactions: Toxicity Produced by "Tranq-Dope" | NIH | National Institute on Drug Abuse | 2025 | $189,672 | August 15, 2025 | July 31, 2027 | SMITH, MARK A | reporter.nih.gov |
| Prescribe to Prevent HIV | NIH | National Institute on Drug Abuse | 2025 | $188,995 | August 15, 2025 | July 31, 2028 | JAWA, RAAGINI | reporter.nih.gov |
| Implementation science to optimize HIV prevention and harm reduction among men who have sex with men engaged in transactional sex in the US | NIH | National Institute on Drug Abuse | 2025 | $181,974 | August 1, 2025 | July 31, 2030 | ATKINS, KAITLYN M | reporter.nih.gov |
| Electronic Cigarettes as a Harm Reduction Strategy Among People with Opioid Use Disorder on Buprenorphine | NIH | National Institute on Drug Abuse | 2025 | $176,754 | June 15, 2025 | May 31, 2030 | PERICOT-VALVERDE, IRENE | reporter.nih.gov |
| The Influence of Spatial Proximity to Sterile Syringe Sources and Secondary Syringe Exchange on HCV Risk Among Rural People Who Inject Drugs | NIH | National Institute on Drug Abuse | 2021 to 2023 | $150,540 | July 6, 2020 | June 2, 2024 | ROMO, ERIC | reporter.nih.gov |
| Mentoring in Patient Oriented Research for Digital Biomarker-Driven Solutions to prevent and Treat Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2025 | $144,252 | September 1, 2025 | August 31, 2030 | CARREIRO, STEPHANIE P | reporter.nih.gov |
| Colliding Epidemics During an Opioid Crisis: Impact of the COVID-19 Pandemic on Determinants of HIV and HCV Transmission Among People Who Inject Drugs | NIH | National Institute on Drug Abuse | 2021 to 2023 | $140,482 | September 1, 2021 | August 31, 2024 | PATEL, ESHAN UDAY | reporter.nih.gov |
| Determinants of transitioning from injecting to smoking fentanyl and methamphetamine and implications for harm reduction implementation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $107,862 | September 1, 2024 | August 31, 2026 | EGER, WILLIAM HENRY | reporter.nih.gov |
| Harm reduction vending machines: Exploring and improving acceptability of a low barrier approach to reducing drug related harms | NIH | National Institute on Drug Abuse | 2024 to 2025 | $107,180 | June 1, 2024 | December 31, 2025 | KIRK, MIA RAE | reporter.nih.gov |
| Harm Reduction Policing? A Qualitative Study of Police Culture and Enforcement Practices Toward People Who Use Drugs Amidst Efforts to Align Public Health and Public Safety Systems | NIH | National Institute on Drug Abuse | 2023 to 2024 | $102,027 | September 1, 2023 | August 31, 2025 | SILBERZAHN, BRADLEY EDWARD | reporter.nih.gov |
| Treatment Utilization During Community Reentry of Opioid Use Disorder Inpatients | NIH | National Institute on Drug Abuse | 2024 to 2025 | $98,512 | September 1, 2024 | August 31, 2026 | NEWBERGER, NOAM | reporter.nih.gov |
| Innovations in Modeling Existing and Emerging Policies to Improve Warning Systems for Opioid Overdoses | NIH | National Institute on Drug Abuse | 2023 to 2024 | $96,668 | September 26, 2023 | September 25, 2025 | RAM, ARCHANA | reporter.nih.gov |
| Risk Environment Effects on Ontological Security Among People Who Use Drugs: An Ethnographic Study | NIH | National Institute on Drug Abuse | 2021 to 2023 | $77,487 | January 1, 2022 | June 21, 2023 | GOLDSHEAR, JESSE LLOYD | reporter.nih.gov |
| Reversal of ventilatory depression by drug mixtures | NIH | National Institute on Drug Abuse | 2023 to 2024 | $75,296 | January 15, 2023 | January 14, 2025 | FLYNN, SHAWN MICHAEL | reporter.nih.gov |
| Utilizing Multi-Methods to Examine the Impact of Xylazine in the Unregulated Drug Supply | NIH | National Institute on Drug Abuse | 2025 | $49,538 | July 1, 2025 | June 30, 2027 | HILL, KATHERINE | reporter.nih.gov |
| A statewide examination of the address-level relationships between residential eviction proceedings and overdose events in Rhode Island | NIH | National Institute on Drug Abuse | 2025 | $49,538 | September 1, 2025 | August 31, 2027 | SKINNER, ALEXANDRA | reporter.nih.gov |
| Evaluation of a Pharmacist-Integrated Model of Opioid Use Disorder Treatment to Increase Naloxone Co-Prescribing in Primary Care | NIH | National Institute on Drug Abuse | 2024 | $48,974 | June 1, 2024 | May 31, 2025 | BOGGIS, JESSE S | reporter.nih.gov |
| Opioid overdose prevention in US higher education settings: a multisite, mixed methods study of college students and institutional leaders | NIH | National Institute on Drug Abuse | 2024 | $43,920 | July 1, 2024 | June 30, 2025 | FREIBOTT, CHRISTINA ELLIOTT | reporter.nih.gov |
| Understanding inequities in harm reduction services provided to persons with opioid use disorder in hospital settings: Harnessing the power of natural language processing. | NIH | National Institute on Drug Abuse | 2024 | $39,866 | September 18, 2024 | September 17, 2025 | ISRAEL, KHADIJA | reporter.nih.gov |
| Exploring Daily-Level Associations Between Protective Behavioral Strategies, Alcohol Use, and Consequences: The Role of Context and Social Determinants of Health within Adolescents and Young Adults | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $35,081 | September 1, 2025 | August 31, 2027 | GREENE, ALLISON | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| New York University School of Medicine | New York, NY | 8 | $80.8 million | 0 | $0 |
| Columbia University | New York, NY | 5 | $36.3 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 10 | $33 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 4 | $32.3 million | 0 | $0 |
| Boston Medical Center | Boston, MA | 3 | $31.7 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 15 | $27.7 million | 0 | $0 |
| Ohio State University | Columbus, OH | 3 | $27.5 million | 0 | $0 |
| Hennepin Healthcare Research Institute | Minneapolis, MN | 1 | $22.4 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 10 | $18.4 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 9 | $15 million | 0 | $0 |
| University of Washington | Seattle, WA | 6 | $14.4 million | 0 | $0 |
| Yale University | New Haven, CT | 9 | $13.6 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 4 | $12.3 million | 0 | $0 |
| University of Chicago | Chicago, IL | 2 | $10.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 2 | $10.1 million | 0 | $0 |
| Brown University | Providence, RI | 6 | $8.1 million | 0 | $0 |
| New York University | New York, NY | 4 | $8 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 6 | $7.8 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 6 | $7.5 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 3 | $6.6 million | 0 | $0 |
| Clear Scientific, LLC | Cambridge, MA | 1 | $6.1 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 2 | $5.8 million | 0 | $0 |
| Indiana University | Bloomington, IN | 3 | $5 million | 0 | $0 |
| University of Florida | Gainesville, FL | 1 | $4.5 million | 0 | $0 |
| Epiodyne, Inc. | San Francisco, CA | 1 | $4.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 1 | $3.9 million | 0 | $0 |
| Washington University | Saint Louis, MO | 3 | $3.8 million | 0 | $0 |
| Instanosis, Inc. | Milford, DE | 2 | $3.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 2 | $3.5 million | 0 | $0 |
| Reacx Pharmaceuticals, Inc. | South San Francisco, CA | 1 | $3.5 million | 0 | $0 |
| Drexel University | Philadelphia, PA | 1 | $3.4 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 3 | $3.4 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 1 | $3.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 3 | $3.3 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 1 | $3.3 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 2 | $3.1 million | 0 | $0 |
| Open Aid Alliance | Missoula, MT | 1 | $3 million | 0 | $0 |
| Serodopa Therapeutics INC | Gainesville, FL | 1 | $2.9 million | 0 | $0 |
| Loyola University Chicago | Maywood, IL | 1 | $2.8 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 2 | $2.8 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 1 | $2.8 million | 0 | $0 |
| Board of Regents, NSHE, obo University of Nevada, Reno | Reno, NV | 2 | $2.7 million | 0 | $0 |
| University of Texas at El Paso | El Paso, TX | 1 | $2.6 million | 0 | $0 |
| University of British Columbia | Vancouver | 2 | $2.6 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 1 | $2.6 million | 0 | $0 |
| Ayuda Medical | Seattle, WA | 1 | $2.6 million | 0 | $0 |
| Consegna Pharma, Inc. | Pittsburgh, PA | 1 | $2.5 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 1 | $2.5 million | 0 | $0 |
| Chestnut Health Systems, Inc. | Bloomington, IL | 3 | $2.4 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 2 | $2.4 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 1 | $2.4 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 1 | $2.4 million | 0 | $0 |
| Clemson University | Clemson, SC | 3 | $2.3 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 1 | $2.2 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 1 | $2.1 million | 0 | $0 |
| Washington State University | Pullman, WA | 1 | $2 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 1 | $1.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 2 | $1.8 million | 0 | $0 |
| Real Prevention, LLC | Clifton, NJ | 1 | $1.7 million | 0 | $0 |
| Rescue Biomedical, LLC | West Lafayette, IN | 2 | $1.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 1 | $1.5 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 2 | $1.5 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 2 | $1.4 million | 0 | $0 |
| Dartmouth-Hitchcock Clinic | Lebanon, NH | 1 | $1.4 million | 0 | $0 |
| Torralva Medical Therapeutics, LLC | Portland, OR | 1 | $1.4 million | 0 | $0 |
| Ndri-Usa, Inc. | New York, NY | 2 | $1.3 million | 0 | $0 |
| Confederated Tribes and Bands of the Yakama Nation | Toppenish, WA | 1 | $1.1 million | 0 | $0 |
| Butler Hospital (providence, Ri) | Providence, RI | 1 | $1.1 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 2 | $1 million | 0 | $0 |
| University of the Pacific | Stockton, CA | 1 | $1 million | 0 | $0 |
| CUNY City College | New York, NY | 1 | $915,814 | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 2 | $888,946 | 0 | $0 |
| University of New Mexico Health Scis CTR | Albuquerque, NM | 1 | $849,872 | 0 | $0 |
| Altrumed LLC | Philadelphia, PA | 2 | $823,910 | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 1 | $762,479 | 0 | $0 |
| Eastern Shoshone Tribe | Fort Washakie, WY | 1 | $759,957 | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 2 | $743,709 | 0 | $0 |
| San Diego State University Foundation | San Diego, CA | 1 | $709,852 | 0 | $0 |
| Ohio University | Athens, OH | 1 | $697,560 | 0 | $0 |
| University of Miami | Coral Gables, FL | 1 | $677,250 | 0 | $0 |
| Public Health Foundation Enterprises | City Of Industry, CA | 1 | $629,866 | 0 | $0 |
| Sri International | Menlo Park, CA | 1 | $628,353 | 0 | $0 |
| North Jersey Aids Alliance ,inc. (njcri) | Newark, NJ | 1 | $583,902 | 0 | $0 |
| Oregon Res Behavioral Intervention Strat | Springfield, OR | 2 | $555,535 | 0 | $0 |
| CSUB Auxiliary for Sponsored Programs Administration | Bakersfield, CA | 1 | $554,922 | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 1 | $554,412 | 0 | $0 |
| Florida International University | Miami, FL | 1 | $519,012 | 0 | $0 |
| Friends Research Institute, Inc. | Baltimore, MD | 1 | $506,459 | 0 | $0 |
| Pirouette Medical | Portsmouth, NH | 1 | $479,080 | 0 | $0 |
| Brandeis University | Waltham, MA | 1 | $470,656 | 0 | $0 |
| New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC | New York, NY | 1 | $470,578 | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 1 | $465,750 | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 1 | $431,750 | 0 | $0 |
| West Virginia University Research Corporation | Morgantown, WV | 1 | $426,105 | 0 | $0 |
| University of Toledo Health Sci Campus | Toledo, OH | 1 | $424,875 | 0 | $0 |
| Rand Corporation | Santa Monica, CA | 1 | $424,545 | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 1 | $415,340 | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 1 | $405,490 | 0 | $0 |
| Biosensics, LLC | Newton, MA | 1 | $400,000 | 0 | $0 |
| Lynthera Corporation | Lancaster, PA | 1 | $375,000 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 151 | $113,641,827 | 0 | $0 |
| 2024 | 149 | $99,005,805 | 0 | $0 |
| 2023 | 125 | $105,261,813 | 0 | $0 |
| 2022 | 88 | $130,469,228 | 0 | $0 |
| 2021 | 46 | $130,764,517 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.